SK Chemicals Co., Ltd. (285130.KS)
Seongnam-si, KR
SK Chemicals Co. Ltd. engages in the manufacturing of chemicals, pharmaceuticals and other biomaterials. It operates through the Green Chemicals and Life Science business divisions. The Green Chemicals business division provides Copolyster, coating and adhesive materials, engineering plastic, Prepreg, Bio and 3D printing materials. The Life Science business division offers pharmaceuticals, vaccines and plasma derivatives. The company was founded in 1969 and is headquartered in Seongnam-si, South Korea.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.40% | -14.02% | -11.75% | -21.41% | -33.82% | -23.90% | -1.18% | -31.19% | -70.06% | -29.81% | -29.81% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%+36.2% ★ Q1'26: +22.2% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+514.7% ★ Q1'26: -160.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+1.0% Q1'26: -4.8% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+0.0% Q1'26: -2.9% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+0.0% Q1'26: -1.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-17.6% ★ Q1'26: +1.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×11.47× Q1'26: -28.62× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 2 Rev. Ana. 2 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
87.84B
est: 1.21T (-92.7%)
|
1.37T
est: 1.37T (+0.2%)
|
1.43T
est: 1.43T (+0.0%)
|
1.21T
est: 1.20T (+0.9%)
|
2.09T
est: 2.18T (-4.2%)
|
1.83T
est: 2.23T (-18.1%)
|
1.75T
est: 2.50T (-30.0%)
|
1.74T
est: 1.65T (+5.5%)
|
2.37T
est: 2.36T (+0.2%)
|
2.75T
2.73T – 2.78T
+16.7% YoY
|
2.94T
2.89T – 2.98T
+6.7% YoY
|
3.18T
3.14T – 3.22T
+8.3% YoY
|
| EBITDA |
-2.88B
est: 208.45B (-101.4%)
|
125.33B
est: 235.98B (-46.9%)
|
107.84B
est: 246.71B (-56.3%)
|
215.59B
est: 208.14B (+3.6%)
|
627.08B
est: 377.04B (+66.3%)
|
343.63B
est: 386.21B (-11.0%)
|
197.35B
est: 432.02B (-54.3%)
|
149.55B
est: 252.38B (-40.7%)
|
188.57B
est: 361.85B (-47.9%)
|
422.15B
418.42B – 425.87B
+16.7% YoY
|
450.44B
443.32B – 457.57B
+6.7% YoY
|
487.89B
481.81B – 493.96B
+8.3% YoY
|
| EBIT |
-10.28B
est: 138.46B (-107.4%)
|
36.90B
est: 156.74B (-76.5%)
|
15.12B
est: 163.87B (-90.8%)
|
143.19B
est: 138.26B (+3.6%)
|
547.60B
est: 250.44B (+118.7%)
|
252.16B
est: 256.53B (-1.7%)
|
84.47B
est: 286.96B (-70.6%)
|
14.00B
est: 150.21B (-90.7%)
|
47.70M
est: 215.37B (-100.0%)
|
251.26B
249.04B – 253.47B
+16.7% YoY
|
268.10B
263.86B – 272.34B
+6.7% YoY
|
290.38B
286.77B – 294.00B
+8.3% YoY
|
| Net Income |
-8.54B
est: 29.34B (-129.1%)
|
6.03B
est: -20.82B (+129.0%)
|
5.02B
est: 10.10B (-50.3%)
|
255.16B
est: 307.49B (-17.0%)
|
168.14B
est: 504.05B (-66.6%)
|
191.27B
est: 191.13B (+0.1%)
|
39.86B
est: 221.82B (-82.0%)
|
8.84B
est: -8.29B (+206.6%)
|
44.65B
est: 76.48B (-41.6%)
|
221.79B
165.34B – 278.23B
+190.0% YoY
|
168.45B
144.53B – 192.36B
-24.1% YoY
|
189.25B
186.19B – 192.31B
+12.3% YoY
|
| SGA |
8.74B
est: 85.99B (-89.8%)
|
83.71B
est: 97.35B (-14.0%)
|
80.96B
est: 101.78B (-20.5%)
|
76.30B
est: 85.87B (-11.1%)
|
112.41B
est: 155.55B (-27.7%)
|
149.60B
est: 159.33B (-6.1%)
|
120.27B
est: 178.23B (-32.5%)
|
155.31B
est: 120.86B (+28.5%)
|
173.46B
est: 173.28B (+0.1%)
|
202.15B
200.37B – 203.94B
+16.7% YoY
|
215.70B
212.29B – 219.12B
+6.7% YoY
|
233.63B
230.73B – 236.54B
+8.3% YoY
|
| EPS |
-436.67
est: 1,244.67 (-135.1%)
|
308.52
est: -883.33 (+134.9%)
|
255.08
est: 428.67 (-40.5%)
|
469.42
est: 13,046.00 (-96.4%)
|
8,586.00
est: 21,385.33 (-59.9%)
|
9,915.20
est: 8,109.00 (+22.3%)
|
2,077.30
est: 9,411.00 (-77.9%)
|
376.00
est: -427.00 (+188.1%)
|
2,306.00
est: 3,939.50 (-41.5%)
|
11,424.00
8,516.65 – 14,331.35
+190.0% YoY
|
8,676.50
7,444.83 – 9,908.17
-24.1% YoY
|
9,748.00
9,590.27 – 9,905.73
+12.3% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-07 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-06 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-05-04 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-30 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 5/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Kodex Energy&Chemicals 117460.KS | 0.94% | 159.4K | 0.45% |
| 2 | Kodex 200 Mid-Small 226980.KS | 0.49% | 66.4K | 0.30% |
| 3 | Kodex 200 Intrinsic Value 223190.KS | 0.06% | 11.3K | 0.30% |
| 4 | Kodex 200ESG 337160.KS | 0.03% | 43.3K | 0.09% |
| 5 | Kodex KOSPI 226490.KS | 0.03% | 217.2K | 0.15% |
| 6 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.03% | 34.3K | 0.42% |
| 7 | Samsung KODEX 200 ETF 069500.KS | 0.03% | 4.81M | 0.15% |
| 8 | Kodex 200TR 278530.KS | 0.03% | 1.48M | 0.05% |
| 9 | Kodex KRX300 292190.KS | 0.02% | 13.5K | 0.05% |
| 10 | Kodex MSCI Momentum 275280.KS | 0.02% | 5.9K | 0.30% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Cheol Kim | Chief Executive Officer & Inside Director | — | male |
| Jae-Hyeon Ahn | Chief Executive Officer, President & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 285130.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
